Zobrazeno 1 - 10
of 6 507
pro vyhledávání: '"van Herk, M."'
Autor:
Price, G., Peek, N., Eleftheriou, I., Spencer, K., Paley, L., Hogenboom, J., van Soest, J., Dekker, A., van Herk, M., Faivre-Finn, C.
Publikováno v:
In Clinical Oncology
Surrogate-free machine learning-based organ dose reconstruction for pediatric abdominal radiotherapy
Autor:
Virgolin, M., Wang, Z., Balgobind, B. V., van Dijk, I. W. E. M., Wiersma, J., Kroon, P. S., Janssens, G. O., van Herk, M., Hodgson, D. C., Zaletel, L. Zadravec, Rasch, C. R. N., Bel, A., Bosman, P. A. N., Alderliesten, T.
Publikováno v:
Physics in Medicine & Biology. 2020 Dec 8;65(24):245021
To study radiotherapy-related adverse effects, detailed dose information (3D distribution) is needed for accurate dose-effect modeling. For childhood cancer survivors who underwent radiotherapy in the pre-CT era, only 2D radiographs were acquired, th
Externí odkaz:
http://arxiv.org/abs/2002.07161
Autor:
Clough, A., Sanders, J., Banfill, K., Faivre-Finn, C., Price, G., Eccles, C.L., Aznar, M.C., Van Herk, M.
Publikováno v:
In Radiography February 2022 28(1):17-23
Autor:
Mbanu, P., Osorio, E. Vasquez, Mistry, H., Malcomson, L., Yousif, S., Aznar, M., Kochhar, R., Van Herk, M., Renehan, A.G., Saunders, M.P.
Publikováno v:
In Cancer Treatment and Research Communications 2022 31
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Brown, S. ∗, †, 1, Beasley, M. ‡, 1, Aznar, M.C. §, Belderbos, J. ¶, Chuter, R. ∗, §, Cobben, D. ∗, §, Faivre-Finn, C. ∗, §, Franks, K. ‡, Henry, A. ‡, ‖, Murray, L. ‡, ‖, Price, G. ∗, §, van Herk, M. §
Publikováno v:
In Clinical Oncology October 2021 33(10):e413-e421
Autor:
Abravan A; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom. azadeh.abravan@manchester.ac.uk.; The Christie NHS Foundation Trust, Manchester, United Kingdom. azadeh.abravan@manchester.ac.uk., Faivre-Finn C; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.; The Christie NHS Foundation Trust, Manchester, United Kingdom., Gomes F; The Christie NHS Foundation Trust, Manchester, United Kingdom., van Herk M; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.; The Christie NHS Foundation Trust, Manchester, United Kingdom., Price G; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.; The Christie NHS Foundation Trust, Manchester, United Kingdom.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Nov; Vol. 131 (10), pp. 1718.
Autor:
Abravan A; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom. azadeh.abravan@manchester.ac.uk.; The Christie NHS Foundation Trust, Manchester, United Kingdom. azadeh.abravan@manchester.ac.uk., Faivre-Finn C; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.; The Christie NHS Foundation Trust, Manchester, United Kingdom., Gomes F; The Christie NHS Foundation Trust, Manchester, United Kingdom., van Herk M; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.; The Christie NHS Foundation Trust, Manchester, United Kingdom., Price G; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.; The Christie NHS Foundation Trust, Manchester, United Kingdom.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Nov; Vol. 131 (8), pp. 1279-1289. Date of Electronic Publication: 2024 Sep 04.
Autor:
Sekhar H; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Kochhar R; Department of Radiology, The Christie NHS Foundation Trust, Manchester, UK., Carrington B; Department of Radiology, The Christie NHS Foundation Trust, Manchester, UK., Kaye T; Department of Radiology, St James' University Hospital, Leeds, UK., Tolan D; Department of Radiology, St James' University Hospital, Leeds, UK., Malcomson L; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Saunders MP; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Sperrin M; Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Sebag-Montefiore D; Leeds Institute of Medical Research, University of Leeds, St James's University Hospital, Leeds, UK., van Herk M; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Renehan AG; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. andrew.renehan@manchester.ac.uk.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Oct; Vol. 131 (7), pp. 1137-1146. Date of Electronic Publication: 2024 Aug 21.
Autor:
Jaikuna T; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom.; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Wilson F; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom., Azria D; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute ICM, Université Montpellier, INSERM 1194 IRCM, Montpellier, France., Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Germany., De Santis MC; Radiation Oncology, Fondazione IRCCS Isituto Nazionale dei Tumori, Milan, Italy., Gutiérrez-Enríquez S; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Campus, Barcelona, Spain., van Herk M; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom., Hoskin P; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom., Kotzki L; University Federation of Radiation Oncology of Mediterranean Occitanie, Gard Cancer Institute ICG, CHU Caremeau, Nimes, France., Lambrecht M; KU Leuven, Department of Radiation Oncology, Leuven, Belgium., Lingard Z; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom., Seibold P; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Seoane A; Medical Physics Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Sperk E; Department of Radiation Oncology, Mannheim Cancer Center, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Paul Symonds R; Leicester Cancer Research Centre, University of Leicester, United Kingdom., Talbot CJ; Leicester Cancer Research Centre, University of Leicester, United Kingdom., Rancati T; Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Rattay T; Leicester Cancer Research Centre, University of Leicester, United Kingdom., Reyes V; Radiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Rosenstein BS; Department of Radiation Oncology, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, NY, USA., de Ruysscher D; Maastricht University Medical Center, Department of Radiation Oncology (Maastro Clinic), GROW School for Oncology and Developmental Biology, Maastricht, the Netherlands., Vega A; Fundación Pública Galega de Medicina Xenómica, Grupo de Medicina Xenómica (USC), Santiago de Compostela, Spain.; Instituto de Investigación Sanitaria de, Santiago de Compostela, Spain.; Biomedical Network on Rare Diseases (CIBERER), Spain., Veldeman L; Ghent University Hospital, Department of Radiation Oncology, Ghent, Belgium., Webb A; Department of Genetics and Genome Biology, University of Leicester, United Kingdom., West CM; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom., Aznar MC; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom., Vasquez Osorio E; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom.
Publikováno v:
Physics and imaging in radiation oncology [Phys Imaging Radiat Oncol] 2024 Sep 07; Vol. 32, pp. 100635. Date of Electronic Publication: 2024 Sep 07 (Print Publication: 2024).